• E-mailtom.michoel@uib.no
  • Phone+47 55 58 41 67
  • Visitor Address
    HIB / Thormøhlensgt. 55
  • Postal Address
    Postboks 7803
    5020 Bergen

I have a broad range of research interests in bioinformatics, computational biology and machine learning, and welcome applications from students in any of these areas. In biology, my main interest is to understand gene regulation and how it is affected by genetic variation. In other words, how does the genome determine which genes are expressed (active) in different cell types, and how do genetic differences between individuals lead to differences in gene expression and ultimately to differences in health and disease traits? My group uses machine learning approaches and large sets of genetic and molecular data to answer these questions. Machine learning is a field at the interface of computer science and statistics that aims to identify correlations and other meaningful patterns in large data sets. Biology is an ideal area for testing and developing new machine learning algorithms, because in biology correlations alone are never enough. For instance, to know that high cholesterol and high blood pressure are often seen together in people with diabetes or heart disease is not very useful, until we establish that in fact, high cholesterol causes high blood pressure, and should therefore be the therapeutic target. To establish similar causal relations at the level of genes, where thousands of genes are expressed in every cell of the human body, influencing each other in untold ways through complex, unknown networks of genetic interactions, is the challenge that my group and I aim to address. In short, to paraphrase a well-known saying: nothing in biology makes sense, except in the light of causal inference.

I teach in the Bachelor and Master programs in Informatics.

I've also contributed to some NORBIS courses:


See http://lab.michoel.info/publications

Academic article
  • Show author(s) (2024). Integration of graph neural networks and genome-scale metabolic models for predicting gene essentiality. npj Systems Biology and Applications.
  • Show author(s) (2023). Plasma cortisol-linked gene networks in hepatic and adipose tissues implicate corticosteroid-binding globulin in modulating tissue glucocorticoid action and cardiovascular risk. Frontiers in Endocrinology. 12 pages.
  • Show author(s) (2022). eQTLs as causal instruments for the reconstruction of hormone linked gene networks. Frontiers in Endocrinology.
  • Show author(s) (2022). Tesla-Rapture: A Lightweight Gesture Recognition System From mmWave Radar Sparse Point Clouds. IEEE Transactions on Mobile Computing. 4946-4960.
  • Show author(s) (2022). Restricted maximum-likelihood method for learning latent variance components in gene expression data with known and unknown confounders. G3: Genes, Genomes, Genetics.
  • Show author(s) (2022). A mechanistic framework for cardiometabolic and coronary artery diseases. Nature Cardiovascular Research. 85-100.
  • Show author(s) (2021). Variation in the SERPINA6/SERPINA1 locus alters morning plasma cortisol, hepatic corticosteroid binding globulin expression, gene expression in peripheral tissues, and risk of cardiovascular disease. Journal of Human Genetics. 625-636.
  • Show author(s) (2021). Changes in the gene expression profile during spontaneous migraine attacks. Scientific Reports. 10 pages.
  • Show author(s) (2021). A Graph Feature Auto-Encoder for the Prediction of Unobserved Node Features on Biological Networks. BMC Bioinformatics. 17 pages.
  • Show author(s) (2020). Model-based clustering of multi-tissue gene expression data. Bioinformatics. 1807-1813.
  • Show author(s) (2020). Comparison between instrumental variable and mediation-based methods for reconstructing causal gene networks in yeast. Molecular Biosystems.
  • Show author(s) (2019). High-Dimensional Bayesian Network Inference From Systems Genetics Data Using Genetic Node Ordering. Frontiers in Genetics. 13 pages.
  • Show author(s) (2018). Causal Transcription Regulatory Network Inference Using Enhancer Activity as a Causal Anchor. International Journal of Molecular Sciences.
Academic literature review
  • Show author(s) (2023). Use of big data and machine learning algorithms to extract possible treatment targets in neurodevelopmental disorders. Pharmacology and Therapeutics. 11 pages.
  • Show author(s) (2023). Causal inference in drug discovery and development. Drug Discovery Today. 17 pages.

More information in national current research information system (CRIStin)